N
TWST icon

NanoDimension’s Twist Bioscience TWST Stock Holding History

NanoDimension’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$10.8M Hold
307,740
– – 43.99% 1
2022
Q2 		$10.8M Hold
307,740
– – 35.22% 1
2022
Q1 		$15.2M Hold
307,740
– – 33.33% 2
2021
Q4 		$23.8M Buy
+307,740
New +$31.6M 21.35% 2

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

NanoDimension's TWST Position: Q3 2022 in Review

NanoDimension held its Twist Bioscience (TWST) position steady in Q3 2022 at 307,740 shares worth $10.8M. The position accounts for 43.99% of the portfolio, ranked #1.

NanoDimension first reported a position in TWST in Q4 2021 and has held it in 4 quarters since. The position peaked at $23.8M in Q4 2021. 221 funds tracked by Wall St. Rank hold TWST as of Q3 2022.

  • NanoDimension held 307,740 shares of Twist Bioscience worth $10.8M as of Q3 2022.
  • NanoDimension left its Twist Bioscience share count unchanged in Q3 2022.
  • Twist Bioscience made up 43.99% of NanoDimension's portfolio in Q3 2022, its #1 holding.
  • NanoDimension first reported a position in Twist Bioscience in Q4 2021 and has held it in 4 quarters since.
  • NanoDimension's Twist Bioscience position peaked at $23.8M in Q4 2021.
  • 221 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2022.

Based on NanoDimension's 13F filing for Q3 2022, filed 9 Nov 2022.